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Abstract
Aim Our aim was to assess bowel function and its effect on
overall quality of life (QOL) when compared to healthy con-
trols after colectomy.
Methods Patients undergoing resection of colorectal neopla-
sia were recruited pre-operatively and followed up at 6 and
12 months, to assess ‘early’ bowel function. Patients who
underwent surgery 2 to 4 years previously were recruited for
assessment of ‘intermediate’ bowel function. Healthy relatives
were recruited as controls. The Memorial Sloan-Kettering
Cancer Centre and EQ-5D questionnaires were used to assess
bowel function and QOL, respectively. Statistical assessment
included regression analyses, parametric and non-parametric
tests. The association between QOL and Memorial Sloan-
Kettering Cancer Centre (MSKCC) scores was evaluated
using Spearman’s rank correlation.
Results Ninety-one patients were recruited for assessment of
‘early’ and 85 for ‘intermediate’ bowel function. There were
85 controls. Patients had a significantly higher number of
bowelmovements at each follow-up (p < 0.001). At 12months
after surgery, patients reported difficulty with gas-stool dis-
crimination. The ‘intermediate’ group were found to have
lower scores for flatus control (<0.001) and total frequency
score (p 0.03), indicating worse function. Patients with higher
total MSKCC scores, no symptoms of urgency and those able
to control flatus reported better QOL (p 0.006, 0.007 and
0.005, respectively) at 6 and 12 months. Gas-stool differenti-
ation and complete evacuation correlated with better QOL in
the ‘intermediate’ bowel function group (p 0.02 and 0.02,
respectively).
Conclusion Colonic resection adversely affects elements of
bowel function up to 4 years after surgery. Good colonic func-
tion, represented by higher MSKCC scores, correlates with
better QOL.
Keywords Bowel function . Colorectal neoplasia . Quality of
life . MSKCC questionnaire
Introduction
Most healthy individuals average one bowel movement per
day [1]. Colorectal physiology involves absorption of water
and electrolytes, coordinated propulsion of faecal mass from
the right colon to the rectum, storage and ultimately, expulsion
[2]. The alteration of bowel anatomy after colonic resection
can lead to a number of functional disturbances which may be
of long-term importance to the patient. Although several stud-
ies have reported bowel, urinary and sexual dysfunction after
rectal cancer treatment [3–5], the relationship between bowel
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function and quality of life (QOL) after colonic resection is
scarcely reported in the literature.
A few studies have reported an increase in stool frequency
following left-sided resection (sigmoid and anterior resection)
for the treatment of colorectal cancer [6–9] and diverticular
disease [10, 11]. Validated questionnaires to assess bowel
function and related QOL were not utilised in these studies.
Instead, bowel function is usually reported as numeric data
from self-constructed questionnaire surveys [6–9]. This
makes it challenging to translate the scanty data that are avail-
able into clinically meaningful information for patients. To
address the gap in our knowledge, we designed a prospective
study to assess ‘early’ (≤12 months after surgery) and ‘inter-
mediate’ (2 to 4 years after surgery) bowel function in patients
undergoing hemicolectomy with en blocmesenteric resection
(open and laparoscopic). Bowel function and its effect on the
QOL were compared to healthy controls. Our proposed hy-
pothesis was that potentially curative hemicolectomy for co-




To assess the effects of surgery on ‘early’ bowel function,
patients were identified during colorectal cancer multidisci-
plinary meetings in four centres and recruited during their
regular pre-operative visits. Patients diagnosed with benign
complex colonic polyps [12, 13] unsuitable for endoscopic
therapy were included and identified through a specialist mul-
tidisciplinary meeting in a single centre. The assessment of
‘intermediate’ bowel function was in eligible patients who
had colonic neoplasia resected 2 to 4 years previously. These
potential participants were identified from prospectively
maintained colorectal cancer databases in two of the hospitals.
Theywere recruited either during their regular follow-up visits
or via postal recruitment with a telephone interview. The con-
trol group consisted of siblings, partners and spouses recruited
for evaluation of ‘early’ bowel function. More than one mem-
ber of each family was approached to compensate for subjects
with no controls.
Inclusion criteria were patients who were either due to un-
dergo, or had undergone, elective right hemicolectomy, trans-
verse colectomy, left hemicolectomy and sigmoid colectomy/
high anterior resection (for lesions located above 15 cm from
the anal verge); pre-operative ASA grade I, II or III and IUCC
stages I–III. Exclusion criteria were inability to consent, diag-
nosis of inflammatory bowel or coeliac disease, rectal neo-
plasm, previous pelvic radiation, previous bowel resection
(colon, stomach or small bowel), bypass surgery or vagotomy,
emergency colonic resection, previous stoma, localised
recurrence of disease during the study period and diagnosis
of anal incontinence prior to surgery. The same exclusion
criteria were applied to the control group.
Data collection
Sociodemographic and clinical data were recorded for both
patient groups. Particular care was taken to record the use of
laxatives, opiate-based analgesia or antibiotics within 4 weeks
of recruitment for all three groups and at 6 and 12months after
surgery for patients who had been recruited pre-operatively.
The caecum, ascending and transverse colon were defined as
the ‘right colon’ and descending and sigmoid colon as the ‘left
colon’ for comparisons between these subgroups. The length
of all resected colonic specimens was recorded after fixation.
Post-operative complications with a potential to have an ad-
verse effect on post-operative bowel function including anas-
tomotic leakage, intra-abdominal abscess formation and fur-
ther abdominal surgery were recorded.
Study questionnaires
MSKCC bowel function questionnaire
Study participants were provided with the Memorial Sloan-
Kettering Cancer Centre (MSKCC) bowel function question-
naire designed to evaluate bowel function following rectal
resection [14] as we were unable to identify a validated ques-
tionnaire developed specifically to evaluate bowel function
following colonic resection. The MSKCC questionnaire was
designed to measure bowel function rather than quality of life
[14, 15] and has been validated against the Faecal
Incontinence Quality of Life Scale (FIQL) and the European
Organisation of Research and Treatment of Cancer Quality of
Life (EORTC) questionnaires: QLQ-C30 (core cancer mod-
ule) and QLC-38 (colorectal cancer specific module) [14].
The questionnaire consists of 18 items that are grouped into
three subscales: frequency, diet and urgency/soilage. The fre-
quency subscale includes six questions regarding the number
of bowel movements per 24 h, stool consistency and the abil-
ity to get to the toilet on time. The dietary subscale comprises
four questions relating to the impact of certain food/drink
items on bowel movements and avoidance of those items.
The urgency/soilage subscale consists of four questions
concerning faecal leakage (day or night and use of pads) and
the impact of bowel function on social activities. In addition to
the three subscales, four individual questions (Q) of clinical
significance are also included: incomplete emptying after a
bowel movement [Q4], having a second bowel movement
within 15 min [Q6], knowing the difference between gas
and bowel movement [Q7] and the ability to control the pas-
sage of wind [Q12]. The responses are given on a five-point
Likert scale for all items apart from the item asking for the
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number of bowel movement per 24 h (categorised into quin-
tiles). Within the three subscales, scores for diet and urgency/
soilage range from 4 to 20 and frequency from 6 to 30. One
total score is obtained by summing all 18 items ranging be-
tween 18 and 90. Higher scores indicate better function.
EQ-5D quality of life questionnaire
The EuroQol EQ-5D questionnaire measures QOL on five
dimensions (mobility, self-care, usual activities, pain/
discomfort and anxiety/depression) and has a scale ranging
from 0 (no quality of life) to 100 (optimal quality of life).
The questionnaire also contains a visual analogue scale (EQ-
VAS) (ranging 0 to 100), representing the patient perspective.
Assessment and follow-up
Patients in the ‘early’ bowel function group were asked to
complete questionnaires at recruitment and at 6 and 12months
after surgery. Patients who described a change in bowel habit
prior to diagnosis of the colonic neoplasm were asked to re-
port their bowel habit and QOL at the time of recruitment and
preceding the onset of bowel symptoms (historic data).
Comparison of questionnaire variables between patients and
controls was made at baseline and then and six and 12 months
follow-up. For the subgroup of patients who reported a change
in bowel habit, the ‘historic’ data were used as the baseline
values rather than the values obtained immediately prior to
surgery.
Both controls and those recruited for assessment of ‘inter-
mediate’ bowel function completed a single set of question-
naires as an assumption was made that a one-off measurement
of bowel function and QOL was representative.
Ethical approval
Ethical approval to conduct the study was obtained from the
National Research Ethics Service (NRES) Committee
London–Stanmore inMay 2011with a substantial amendment
to allow postal follow-up in September 2011 (REC reference
11/LO/0294).
Power calculation and statistical analysis
The power calculation was based on results from a study con-
ducted by the authors of the MSKCC questionnaire. That
study was designed to measure functional outcomes and
QOL in patients undergoing rectal cancer surgery [16]. Six-
month follow-up data suggested that bowel function was clin-
ically worse when a drop of five points in the median total
score was observed [16]. We calculated that a sample size of
85 participants in each group would give 90% power to dem-
onstrate a difference in the median total score of five between
the patients and controls, assuming the α value of 0.05. To
allow for a 10 to 15% loss of patients, we aimed to recruit 98
patients in the ‘early’ bowel function group.
The Fisher’s exact test and the unpaired t test were used for
analysis of categorical and continuous variables, respectively.
Continuous data with skewed distribution were examined
using the Mann-Whitney test. Linear regression allowed ad-
justment for the differences in demographics between the two
groups. Log transformation was performed for positively
skewed data using linear regression, whereas bootstrapping
methods alongside the regression methods were used to ana-
lyse negatively skewed outcomes. The results are presented as
regression coefficients, which is the mean difference in the
outcome between the groups reported as the value for the
patient group minus the value for the control group.
Therefore, a positive value suggests higher scores and better
function for the patient group. The exception is the number of
bowel movements per 24 h, which is reported as the ratio of
the number of bowel movements in the patient group com-
pared to that observed in the control group. The Spearman’s
rank correlation was performed to evaluate the relationship
between the bowel function and QOL, as well as between
the MSKCC items and the bowel length excised.
Results
Demographic data
For assessment of ‘early’ bowel function, a total of 121 pa-
tients were recruited prior to surgery and data for 91 patients
were analysed. Reasons for exclusion were loss to follow-up
(n = 15), stoma formation (n = 8), death during the study
period (n = 5), emergency surgery (n = 1) and rectal cancer
(n = 1). Approximately 15% of patients approached in the
clinic declined to take part. Eighty-five controls agreed to
participate in the study.
A total of 106 patients who underwent surgery 2 to 4 years
previously were invited to take part, of whom 85 agreed to
participate. All patients approached in the clinics (n = 48)
agreed to participate with the exception of one. Fifty-eight
invitation letters were posted to patients, of whom 40 agreed
to participate (71% response rate). Of the non-participants,
two were lost to follow-up, six declined to participate and
ten did not respond.
Group comparison of demographic data is presented in
Table 1. The control group were found to be younger, more
likely to be married and to be working at recruitment and less
likely to be diabetic, compared to both patient groups. Patients
were more likely to use laxatives and anti-diarrhoeal agents
6 months after surgery although this difference was not ob-
served at 12 months. General demographics of patients re-
cruited for assessment of ‘intermediate’ bowel function were
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similar to that of the patients recruited prior to surgery. This
group were also more likely to use laxatives.
MSKCC questionnaire
Thirty-five patients in the group recruited for assessment of
‘early’ bowel function reported a change in bowel habit prior
to diagnosis of colonic neoplasia. Therefore, their documented
scores preceding the onset of symptomswere used as baseline.
For the purposes of this study, we present the number of bowel
movements per 24 h independently and include the values in
the MSKCC frequency score as per the questionnaire guide-
lines. Patients experienced a significantly higher number of
bowel movements per 24 h (Fig. 1). At 6 months after surgery,
31% of patients experienced more than three motions per day,
with an additional 42% experiencing more than one. This
compares with figures for controls of 14 and 24%, respective-
ly (p < 0.001). At 12 months after surgery, the corresponding
figures are 30 and 38% (p < 0.001). Patients at 2 to 4 years
after surgery reported three or more motions per day in 20%
and more than one per day in 34% (p > 0.001).
After surgery, there was a trend to lower scores, indicating
worse function, in all components of the MSKCC question-
naire except the dietary subclass and Q4 at 12 months after
surgery (Table 2). Lower scores were reported in the unadjust-
ed analyses for the urgency item (p 0.008) and gas-stool dif-
ferentiation at six and 12 months after surgery (p 0.05 and
<0.001, respectively). These changes were also present in







(n = 91) p (n = 85) p
M:F 34:51 43:47 0.36 49:36 0.03
Mean (SD) age 58.2 (13.4) 71.2 (10.5) <0.001c 69.0 (11.2) <0.001c
Ethnicity 0.34 0.07
White 77 (92%) 79 (87%) 68 (81%)
Other 7 (8%) 11 (13%) 16 (19%)
Social status
Single 11 (13%) 5 (5%) 0.001 13 (16%) 0.007
Married 66 (78%) 64 (70%) 52 (63%)
Living with partner 7 (8%) 6 (7%) 6 (7%)
Widowed 1 (1%) 16 (18%) 12 (14%)
Employment
Retired 37 (44%) 70 (77%) <0.001 63 (75%) <0.001
Unemployed 5 (6%) 8 (9%) 5 (6%)
Working 50 (51%) 13 (14%) 16 (19%)
Laxatives
Baseline 1 (1%) 8 (9%) 0.02 9 (11%) 0.02
6 months 1 (1%) 12 (14%) 0.002
12 months 1 (1%) 5 (6%) 0.21
Antibiotics 1 (1%) 0 (0%) 0.48 5 (6%) 0.21
Anti-diarrhoeal medication
Baseline 1 (1%) 0 (0%) 0.48 5 (6%) 0.21
6 months 1 (1%) 11 (13%) 0.005
12 months 1 (1%) 5 (6%) 0.21
Opiates
Baseline 5 (6%) 2 (2%) 0.27 4 (5%) 1.00
6 months 5 (6%) 0 (0%) 0.06
12 months 5 (6%) 1 (1%) 0.11
Diabetes 1 (1%) 10 (11%) 0.01 11 (13%) 0.005
BMI 27.2 (4.8) 26.1 (5.6) 0.18c 27.3 (25.0, 31.4) 0.22d
a p values correspond to comparison the ‘early’ bowel function group vs. control group
b p values correspond to comparison the ‘intermediate’ bowel function group vs. control group
cUnpaired t test, data presented as mean (SD)
dMann-Whitney test, data presented as median (IQR)
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the ‘intermediate group’, at 2 to 4 years after surgery, along
with difficulty controlling flatus (p < 0.001). After adjusting
for the differences in demographics, however, statistically sig-
nificant differences remained for fewer items (Tables 3 and 4).
These included an increase in the number of bowel move-
ments at all follow-up points, reduced gas-stool differentiation
at 12 months, reduced flatus control and a lower frequency
score (worse function) at 2 to 4 years. No association was
observed between the bowel length excised and any of the
MSKCC items.
EQ-5D questionnaire
No difference in the QOL between patients and controls was
observed at any time point (Table 5). A weakly positive cor-
relation was observed between the EQ-VAS score and flatus
control (rs 0.30, p 0.005), the urgency score (rs 0.29, p 0.007)
and the total MSKCC score (rs 0.31, p 0.006) at 6 months after
surgery, indicating that those with higher scores have better
QOL. A similar relationship between the EQ-VAS and com-
plete emptying was seen at 12 months (rs 0.34, p 0.01). In the
‘intermediate’ bowel function group, complete evacuation
was positively correlated with both EQ-5D-QOL and EQ-
VAS (rs 0.29, p 0.007 and rs 0.25, p 0.02, respectively) where-
as gas-stool differentiation was correlated with EQ-5D-QOL
variable only (p 0.02).
Right- vs. left-sided resections
Both patient cohorts undergoing right- or left-sided resections
had similar demographic details and post-operative outcomes
(Tables 6 and 7). Care involved the use of an enhanced recov-
ery programme in all patients and over 80% of procedures
were laparoscopic. Anastomotic leakage occurred only in
two patients, recruited for the assessment of ‘early’ bowel
function group. These followed left-sided resections and both
were successfully treated with antibiotics only.
No difference in QOL between the groups was observed at
any time point after surgery. At 6 and 12 months follow-up,
patients who underwent left-sided resections experienced a
higher number of bowel movements [2.0 (1.5, 3.3) vs. 1.5
(1.0, 2.5), p 0.04 and 2.0 (1.5, 3.0) vs. 1.5 (1.0, 2.0), p 0.002,
respectively]. They also reported lower scores for Q6 (needing a
second bowel movement within 15 min) indicating worse out-
come [4 (3, 5) vs. 5 (4, 5) at both time points, p 0.001 and 0.01,
respectively]. Although there was no statistically significant dif-
ference between the groups for the number of bowelmovements
per 24 h in the ‘intermediate group’, overall, a lower frequency
score was observed following right-sided resections [24 (21, 26)
vs. 25 (23, 27), p 0.03], indicating worse function.
Discussion
Almost 50% of patients undergoing surgery for colonic neo-
plasia have concerns about post-operative bowel function
[17]. This study was motivated by the need to generate an
estimate of bowel dysfunction after colectomy and its effect
on QOL, as the literature on the subject is sparce. Assuming
that the total MSKCC score represents the overall bowel func-
tion, the results of our study suggest that bowel function and
QOL after colectomy for neoplasia are comparable to that of
healthy controls. However, if one considers bowel frequency
alone, it is significantly increased in one third of patients at 6
and 12 months after surgery and in one quarter at 2 to 4 years.
One in five patients has more than three motions per day 2 or
more years after surgery. At 1 year after surgery, patients re-
ported having difficulty with gas-stool discrimination and at 2
to 4 years, there is difficulty controlling flatus. However, pa-
tients do not seem to perceive problems identified after sur-
gery as affecting their overall QOL when assessed by EQ-5D
and EQ-VAS scores. Despite this, correlation existed between
several items of the MSKCC and better QOL: lack of urgency,
an ability to control flatus, full evacuation and satisfactory
gas-stool differentiation.
This is the largest study published to date designed to eval-
uate bowel function following colectomy for neoplasia. Its
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movements per 
24 hours
p <0.001 p <0.001 p <0.001p 0.628
Fig. 1 Number of bowel
movements split into quintiles at
each time point
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inclusion of controls and assessment of early and intermediate
outcomes. We utilised a validated questionnaire designed spe-
cifically to assess bowel function following rectal resections.
Although such a questionnaire is not currently available for
patients following colectomy, the results of this study suggest
that some patients experience bowel dysfunction and therefore
could be used as a platform for future studies of qualitative
design. We also utilised a well-established QOL questionnaire
that is simple and easy to complete, choosing this to maximise
compliance.
The observed increase in bowel frequency after surgery in a
proportion of our patients could be due to a number of factors.
Table 2 MSKCC questionnaire
linear regression analysis for
‘early’ bowel function group
Median (IQR) score
for patient group
Median (IQR) score for
control group
pa
Baseline early group (n = 91)
Bowel movements per 24 hours 1 (1, 2) 1 (1, 2) 0.40
Frequency score 26 (22, 28) 26 (23, 27) 0.45
Dietary score 19 (16, 20) 16 (14, 18) <0.001
Urgency score 20 (20, 20) 20 (20, 20) 0.87
Complete emptying (Q4) 4 (3, 5) 4 (4, 4) 0.90
2nd bowel movement < 15 min (Q6) 5 (4, 5) 4 (4, 5) 0.09
Gas-stool differentiation (Q7) 5 (4, 5) 5 (5, 5) 0.16
Flatus control (Q12) 4 (4, 5) 4 (4, 5) 0.93
Total score 80 (76, 85) 79 (74, 83) 0.09
6 months follow-up
Bowel movements per 24 hours 2 (1, 3) 1 (1, 2) <0.001
Frequency score 25 (22, 26) 26 (23, 27) 0.06
Dietary score 18 (15, 20) 16 (14, 18) 0.01
Urgency score 20 (18, 20) 20 (20, 20) 0.008
Complete emptying (Q4) 4 (3, 4) 4 (4, 4) 0.12
2nd bowel movement < 15 min (Q6) 4 (3, 5) 4 (4, 5) 1.00
Gas-stool differentiation (Q7) 5 (4, 5) 5 (5, 5) 0.05
Flatus control (Q12) 4 (4, 5) 4 (4, 5) 0.27
Total score 78 (72, 82) 79 (74, 83) 0.32
12 months follow-up
Bowel movements per 24 hours 2 (1, 2.5) 1 (1, 2) <0.001
Frequency score 24 (22, 27) 26 (23, 27) 0.07
Dietary score 18 (16, 20) 16 (14, 18) 0.005
Urgency score 20 (18, 20) 20 (20, 20) 0.004
Complete emptying (Q4) 4 (3, 4) 4 (4, 4) 0.65
2nd bowel movement < 15 min (Q6) 4 (3, 5) 4 (4, 5) 0.67
Gas-stool differentiation (Q7) 5 (4, 5) 5 (5, 5) <0.001
Flatus control (Q12) 4 (4, 5) 4 (4, 5) 0.43
Total score 79 (70, 84) 79 (74, 83) 0.33
Intermediate group (n = 85)
Bowel movements per 24 hours 2 (1, 3) 1 (1, 2) <0.001
Frequency score 24 (21, 26) 26 (23, 27) 0.03
Dietary score 18 (16, 20) 16 (14, 18) 0.009
Urgency score 20 (19, 20) 20 (20, 20) 0.04
Complete emptying (Q4) 4 (3, 5) 4 (4, 4) 0.10
2nd bowel movement < 15 min (Q6) 4 (3, 5) 4 (4, 5) 0.95
Gas-stool differentiation (Q7) 5 (4, 5) 5 (5, 5) 0.002
Flatus control (Q12) 4 (3, 4) 4 (4, 5) <0.001
Total score 81 (73, 84) 79 (74, 83) 0.08
aMann-Whitney test
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It has been proposed that high ligation of the inferior mesen-
teric artery at left hemicolectomy can lead to damage of the
lower mesenteric ganglion [18–20], increased colonic motility
and diarrhoea [21]. Loss of the ileocaecal valve [22] and ex-
cision of the right colon [23] may lead to bile acid malabsorp-
tion, increased motility, mucus secretion and stimulation of
defecation [24]. The right colon has the greatest colonic ab-
sorptive capacity [25] and the contents reside there for longer
than other parts, which may explain the observed increased
incidence of diarrhoea following right hemicolectomy. Adachi
et al. [7] reported that increased specimen length was associ-
ated with worse functional outcomes following sigmoid
colectomy (p < 0.05). We did not find this: however, the
number of patients included in this study was relatively small
and colonic specimens were measured after fixation in forma-
lin, making conclusions difficult to translate to clinical
practice.
Although we found a weak correlation between several
MSKCC items and the EQ-5D QOL and EQ-VAS scores, the
overall QOL of patients in our study at each follow-up point was
comparable to controls, in keeping with the previously pub-
lished studies. Theodoropoulus et al. [26] reported the use of
more detailed QOL questionnaires including SF-36, EORTC
QLQ-C30, QLQ-CR29 and GIQLI questionnaire to evaluate
patients’ QOL at 1, 6 and 12 months after laparoscopic
colectomy. At 6 and 12 months after surgery, almost all QOL
Table 3 MSKCC questionnaire
linear regression analysis for
‘early’ bowel function group
Mean (95% CI) group differencea p
Baseline ‘early’ bowel function group [n = 91]b
Bowel movements per 24 hoursc 0.95 (0.78, 1.16) 0.61
Frequency score 0.1 (−1.2, 1.4) 0.92
Dietary score 1.1 (0.2, 2.1) 0.02
Urgency score 0.3 (−0.3, 1.0) 0.39
Complete emptying (Q4) 0.1 (−0.3, 0.5) 0.75
2nd bowel movement < 15 min (Q6) 0.2 (−0.1, 0.6) 0.26
Gas-stool differentiation (Q7) 0.0 (−0.3, 0.2) 0.75
Flatus control (Q12) −0.1 (−0.4, 0.2) 0.72
Total score 1.8 (−1.2, 4.2) 0.19
‘Early’ bowel function group at 6 monthsd
Bowel movements per 24 hoursc 1.59 (1.31, 1.92) <0.001
Frequency score −0.3 (−1.6, 0.9) 0.61
Dietary score 0.1 (−0.9, 1.2) 0.90
Urgency score −0.6 (−1.5, 0.2) 0.15
Complete emptying (Q4) −0.1 (−0.5, 0.3) 0.52
2nd bowel movement < 15 min (Q6) −0.1 (−0.6, 0.3) 0.48
Gas-stool differentiation (Q7) −0.1 (−0.4, 0.2) 0.31
Flatus control (Q12) −0.1 (−0.4, 0.2) 0.55
Total score −1.1 (−4.1, 2.1) 0.51
‘Early’ bowel function group at 12 monthse
Bowel movements per 24 hoursc 1.45 (1.21, 1.75) <0.001
Frequency score −1.2 (−2.7, 0.1) 0.07
Dietary score 0.7 (−0.3, 1.6) 0.16
Urgency score −0.5 (−1.4, 0.3) 0.24
Complete emptying (Q4) 0.1 (−0.3, 0.4) 0.72
2nd bowel movement < 15 min (Q6) −0.1 (−0.6, 0.3) 0.54
Gas-stool differentiation (Q7) −0.4 (−0.7, −0.1) 0.01
Flatus control (Q12) −0.4 (−0.8, 0.0) 0.06
Total score −1.5 (−4.6, 1.6) 0.36
a Regression coefficient where a higher value indicates higher score and therefore better function for patients
b Adjusted for age, marital status, employment, laxatives at baseline and diabetes
c Due to log transformation, results are reported as the ratio of number of movements in the patient group
dAdjusted for age, marital status, employment, diabetes, laxatives and anti-diarrhoeal medication
e Adjusted for age, marital status, employment and diabetes
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scores were better than baseline and were comparable to the
general population values. In addition, Ramsey et al. [5]
reviewed QOL of long-term CRC survivors more than 5 years
after their initial treatment and found that patients had a relative-
ly high perceived QOL compared to age-matched controls. It
may be that the use of a more complex, and presumably sensi-
tive, QOL measure would have identified a reduction in early
QOL but we chose to use a relatively simple approach in order
to encourage recruitment and avoid loss to follow-up.
Despite the prospective nature of this adequately powered
case-controlled study and the use of validated questionnaires,
there are several potential limitations that may affect the
generalisability of our conclusions. A selection bias may exist
as only patients and controls willing and able to take part in the
study were recruited. Recall bias is common in self-reported
surveys and a proportion of our patients presented with a
change in bowel habit which may have had an effect on the
baseline values for both the MSKCC and EQ-5D question-
naires. Although loss to follow-up was relatively low (12%),
these patients may have been embarrassed to talk about their
bowel function after surgery due to the severity of their symp-
toms, thus potentially minimising functional problems report-
ed after colectomy. In addition, having survived cancer may
have strengthened positive health perceptions in this relatively
older patient population when they compared their health to
that at the time of cancer diagnosis. Our patient population
was older than controls and had a higher incidence of diabetes.
However, when adjusted for those demographic differences,
Table 5 EQ-5D questionnaire
linear regression analysis Mean (95% CI) group difference
a p
Baseline ‘early’ bowel function group [n = 91]b
EQ-5D-QOL −0.01 (−0.07, 0.05) 0.78
EQ-VAS −2.5 (−9.3, −3.9) 0.45
‘Early’ bowel function group at 6 monthsc
EQ-5D-QOL −0.02 (−0.08, 0.04) 0.52
EQ-VAS −3.9 (−9.6, 1.8) 0.18
‘Early’ bowel function group at 12 monthsd
EQ-5D-QOL 0.00 (−0.06, 0.06) 0.95
EQ-VAS −0.3 (−5.9, 6.1) 0.93
‘Intermediate’ bowel function group [n = 85]e
EQ-5D-QOL −0.04 (−0.11, 0.04) 0.31
EQ-VAS −2.1 (−7.8, 3.6) 0.47
a Regression coefficient where a higher value indicates higher score and therefore better function for patients
b Adjusted for age, marital status, employment, diabetes and laxatives
c Adjusted for age, marital status, employment, diabetes, laxatives and anti-diarrhoeal medication
dAdjusted for age, marital status, employment and diabetes
e Adjusted for age, sex, marital status, employment, laxative use and diabetes
Table 4 MSKCC questionnaire
linear regression analysis for
‘intermediate’ bowel function
group
Mean (95% CI) group differencea p
‘Intermediate’ bowel function group [n = 85]b
Bowel movements per 24 hoursc 1.44 (1.20, 1.73) <0.001
Frequency score −1.5 (−3.0, 0.0) 0.03
Dietary score 0.6 (−0.4, 1.6) 0.23
Urgency score −0.6 (−1.5, 0.3) 0.20
Complete emptying (Q4) −0.1 (−0.5, 0.3) 0.47
2nd bowel movement < 15 min (Q6) −0.1 (−0.5, 0.3) 0.54
Gas-stool differentiation (Q7) −0.2 (−0.5, 0.1) 0.12
Flatus control (Q12) −0.6 (−1.0, −0.3) <0.001
Total score −2.7 (−36.0, 0.7) 0.11
a Regression coefficient where a higher value indicates higher score and therefore better function for patients
b Adjusted for age, sex, marital status, employment, laxative use and diabetes
c Due to log transformation, results are reported as the ratio of number of movements in the patient group
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Table 6 Demographics details of
right- vs. left-sided colonic
resections for patients recruited







M:F 22 (47%):25 (53%) 21 (49%):22 (51%) 1.00
ASA grade 0.22
I 7 (18%) 9 (26%)
II 20 (51%) 21 (60%)
III 12 (31%) 5 (14%)
Type of surgery 0.09
Laparoscopic 41 (87%) 37 (86%)
Open 5 (11%) 1 (2%)
Converted 1 (2%) 5 (12%)
Median (IQR) LOS, daysa 6 (4, 10) 5 (4, 7) 0.29
30-day complications 14 (30%) 13 (30%) 1.00
30-day readmission 0 (0%) 5 (12%) 0.02
30-day reoperation 0 (0%) 0 (0%) –
Mean (SD) specimen length cmb 29.4 (12.8) 27.2 (9.1) 0.36
IUCC stage 0.19
I 9 (20%) 11 (26%)
II 18 (41%) 14 (33%)
III 17 (39%) 14 (33%)
Benign 0 (0%) 4 (9%)
Distant recurrence at 6 months 2 (5%) 0 (0%) 0.50
Distant recurrence at 12 months 2 (4%) 1 (2%) 1.00
Chemotherapy 19 (40%) 16 (34%) 0.97
aMann-Whitney test
b Unpaired t test
Table 7 Demographic details of
right- vs. left-sided colonic resec-
tions for patients recruited for as-







M:F 26 (54%):22 (46%) 10 (27%):27 (73%) 0.015
ASA grade 0.22
I 7 (15%) 8 (22%)
II 33 (68%) 26 (70%)
III 7 (15%) 1 (3%)
Not available 1 (2%) 2 (5%)
Type of surgery 0.25
Laparoscopic 38 (79%) 32 (87%)
Open 8 (16%) 3 (8%)
Converted 2 (5%) 2 (5%)
Median (IQR) LOS, daysa 4 (3, 6) 5 (4, 6) 0.15
30-day complications 14 (29%) 6 (16%) 0.02
30-day readmission 4 (8%) 1 (3%) 0.30
30-day reoperation 1 (2%) 1 (3%) 0.68
Mean (SD) specimen length cm** 42.1 (17.4) 28.4 (10.3) <0.001
IUCC stage 0.19
I 6 (12%) 10 (27%)
II 23 (48%) 12 (32%)
III 19 (40%) 15 (41%)
Distant recurrence 1 (2%) 2 (5%) 0.50
aMann-Whitney test
** unpired t test
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the MSKCC and EQ5D scores reported by both groups were
comparable at baseline.
The results of this study suggest that aspects of bowel func-
tion may be adversely affected years after colectomy, and
further study would be beneficial in order define the problem
and improve treatment. It would be appropriate to inform pa-
tients who wish to know that increased bowel frequency after
surgery affects approximately one in five. A study with longer
follow-up would clarify the discrepancy observed between the
‘early’ and ‘intermediate’ bowel function following different
resections, and semi-structured interviews might help identify
issues that are specific for this patient group. In addition, the
adverse functional outcomes identified in this study may pro-
vide an incentive to find an alternative to segmental colectomy
for patients who are likely to be node negative [27].
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